.After antibody-drug conjugate (ADC) professional Seagen was actually offered to Pfizer in 2014 for ...
.On the heels of a phase 3 succeed that neglected to make an impression on financiers, Ironwood Phar...
.Don't stop Monte Rosa Rehabs now. The Boston-based biotech is actually having a ball after signing ...
.Accept to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings as...
.Celebrating his firm's upsized initial public offering (IPO), Septerna chief executive officer Jeff...
.AbbVie has actually come back to the source of its own antipsychotic goliath Vraylar trying to find...
.GenSight Biologics is actually weeks off of lacking loan. Once more. The biotech just has sufficien...
.Monopar Therapies is recouping a drug coming from the scrap heap of AstraZeneca's uncommon illness ...
.Along with brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of ...
.After creating a genetics treatment collaboration with Dyno Rehabs in 2020, Roche is back for even ...